date,title,source
Oct-31-18,Strong IPO pace continued in October but some cracks are showing,American City Business Journals
Nov-16-18,Kodiak Sciences Announces Third Quarter 2018 Financial Results and Recent Business Highlights,PR Newswire
Dec-21-18,Kodiak Sciences Announces Completion of 12-Week Phase 1a Study of KSI-301 in Patients with Diabetic Macular Edema Demonstrating Safety and Durability of Responses Following Single Dose of Intravitreal Anti-VEGF Antibody Biopolymer Conjugate,PR Newswire
